Instil Bio, Inc.(TIL)

Biotechnology · Dallas, TX

$6.99+0.04 (+0.58%)

Delayed quote: Oct 6, 2026, 2:45 PM EDT

EV/FCF Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T18:53:24.256Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:53:24.256Z.

Quote observation: 2026-10-06T18:45:51.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 47,406,012
Total debt · period ending 2026-06-30: 3,670,000
Cash · period ending 2026-06-30: 5,541,000
TTM free cash flow · period ending 2026-06-30: -23,612,000

FMP input reference: 1639651ea08d8a43111aa8341d4d68762a5dc33ecadd1da8a92c037613eb041e

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

TIL EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

TIL Competitors' EV/FCF Ratio

TIL

Instil Bio, Inc.

Current

Market Cap

$47.41M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CELU

Celularity Inc.

vs TIL

Market Cap

$46.31M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LITS

Lite Strategy, Inc.

vs TIL

Market Cap

$47.81M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HOWL

Werewolf Therapeutics, Inc.

vs TIL

Market Cap

$45.03M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SNWV

SANUWAVE Health Inc.

vs TIL

Market Cap

$45.20M

EV/FCF Ratio

13.32x

TTM Avg

37.31x

3Y Avg

6410.23x

5Y Avg

6410.23x

APLM

Apollomics, Inc.

vs TIL

Market Cap

$48.82M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INMB

INmune Bio, Inc.

vs TIL

Market Cap

$49.18M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DRIO

DarioHealth Corp.

vs TIL

Market Cap

$44.27M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TELA

TELA Bio, Inc.

vs TIL

Market Cap

$49.21M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MBOT

Microbot Medical Inc.

vs TIL

Market Cap

$49.44M

EV/FCF Ratio

N/A

TTM Avg

12.79x

3Y Avg

13.79x

5Y Avg

13.79x

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Instil Bio, Inc. (TIL)	$47.41M	N/A	N/A	N/A	N/A
Celularity Inc. (CELU)vs ›	$46.31M	N/A	N/A	N/A	N/A
Lite Strategy, Inc. (LITS)vs ›	$47.81M	N/A	N/A	N/A	N/A
Werewolf Therapeutics, Inc. (HOWL)vs ›	$45.03M	N/A	N/A	N/A	N/A
SANUWAVE Health Inc. (SNWV)vs ›	$45.20M	13.32x	37.31x	6410.23x	6410.23x
Apollomics, Inc. (APLM)vs ›	$48.82M	N/A	N/A	N/A	N/A
INmune Bio, Inc. (INMB)vs ›	$49.18M	N/A	N/A	N/A	N/A
DarioHealth Corp. (DRIO)vs ›	$44.27M	N/A	N/A	N/A	N/A
TELA Bio, Inc. (TELA)vs ›	$49.21M	N/A	N/A	N/A	N/A
Microbot Medical Inc. (MBOT)vs ›	$49.44M	N/A	12.79x	13.79x	13.79x

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/FCF Ratio: N/A

TIL EV/FCF Ratio Metrics

TIL Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

Related Metrics